Zimmer Partners, LP Crinetics Pharmaceuticals, Inc. Transaction History

Zimmer Partners, LP

  • $4.61 Billion
  • Q1 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 14, 2024
BUY
$25.62 - $37.07 $735,294 - $1.06 Million
28,700 New
28,700 $1.02 Million
Q4 2018

Feb 14, 2019
SELL
$22.4 - $35.39 $224,000 - $353,900
-10,000 Closed
0 $0
Q3 2018

Nov 14, 2018
BUY
$22.66 - $36.8 $226,600 - $368,000
10,000 New
10,000 $287,000

Others Institutions Holding CRNX

# of Institutions
220
Shares Held
75.8M
Call Options Held
631K
Put Options Held
749K
View Full List

About Crinetics Pharmaceuticals, Inc.

CRNX Quotes by TradingView
  • Ticker CRNX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 53,752,800
  • Market Cap $2.41B
  • Description
  • Crinetics Pharmaceuticals, Inc., a clinical stage pharmaceutical company, focuses on the discovery, development, and commercialization of therapeutics for rare endocrine diseases and endocrine-related tumors. Its lead product candidate is Paltusotine, an oral selective nonpeptide somatostatin receptor type 2 agonist that has completed phase III ...
More about CRNX
Track This Portfolio

Track Zimmer Partners, LP Portfolio

Follow Zimmer Partners, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Zimmer Partners, LP, based on Form 13F filings with the SEC.

News

Stay updated on Zimmer Partners, LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email